Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Core24
- Development stage
- Unknown
- Lead developer
- Getz Pharma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Core24 is an oral multivitamin and mineral supplement developed and marketed by Getz Pharma. It is formulated with a combination of 24 essential vitamins and minerals, including Vitamin A, B-complex vitamins (B1, B2, B3, B5, B6, B7, B9, B12), Vitamin C, Vitamin D3, Vitamin E, and essential minerals such as iron, zinc, magnesium, calcium, and copper. Core24 is indicated as a daily nutritional supplement to address nutritional deficiencies, support immune function, aid in the metabolism of macronutrients, and promote overall health and well-being, particularly in individuals with unbalanced diets, malabsorption issues, or during recovery from illness.
- Brand names
- Core 24Core24Core-24
- Other names
- Getz Life Core 24Multivitamins & Mineralsmultivitamins and minerals
Beyond the preview
Go deeper on Core24.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Core24.